Inducible carboxypeptidase activity: A role in clot lysis in vivo

Circulation

Volumn 93, Issue 7, 1996, Pages 1328-1330

  Redlitz, Alexander ^a   Nicolini, Francesca A ^a   Malycky, Janis L ^a   Topol, Eric J ^a   Plow, Edward F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

carboxypeptidase; plasminogen activators; thrombolysis; thrombosis

Indexed keywords

CARBOXYPEPTIDASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; DOG; ENZYME ACTIVITY; FIBRINOLYTIC THERAPY; HEART INFARCTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029874692     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.7.1328     Document Type: Article

References (10)

1. Pannell R, Black J, Gurewich V. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. J Clin Invest. 1988;81:853-859.
2. Fleury V, Angles-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry. 1991;30:7630-7638.
3. Redlitz A, Tan AK, Eaton DL, Plow EF. Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest. 1995;96: 2534-2538.
4. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem. 1995;270:14477-14484.
5. Hendriks D, Scharpe S, van Sande M, Lommaert MP. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem. 1989;27:277-285.
6. Skidgel RA. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol Sci. 1988;9:299-304.
7. Wang W, Hendriks DF, Scharpé SS. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem. 1994;269:15937-15944.
8. Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem. 1991;266: 21833-21838.
9. Nicolini FA, Lee P, Rios G, Kottke-Marchant K, Topol EJ. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Circulation. 1994;89:1802-1809.
10. Stringer HA, van Swieten P, Heijnen HF, Sixma JJ, Pannekoek H. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance: studies with thrombi generated in the Chandler loop. Arterioscler Thromb. 1994;14: 1452-1458.